Silence Therapeutics is based in London, United Kingdom. It has raised $120M in total funding. Latest round: Series B.
Silence Therapeutics is based in London, United Kingdom. Silence Therapeutics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2024. The round record for Silence Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include 5AM Ventures, Frazier Life Sciences, Logos Capital, Nextech Invest Ltd, Redmile Group, TCGX and 1 others. 7 distinct backers are named across the disclosed rounds.
Silence Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in London below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026